[CIS PIDD] [cis-pidd] ADA2 deficiency - Infliximab dosage

[CIS-PIDD]

Do you guys add methotrexate to prevent auto-antibody formation?
(Fabian: our patients like adalimumab…)
Best, Bodo
****************************************
Univ.-Prof. Dr. med. B. Grimbacher

Scientific-Director
CCI-Center for Chronic Immunodeficiency
UNIVERSITÄTSKLINIKUM FREIBURG
Tel.: 0761 270-77731  Fax: -77744
Breisacherstraße 115, 79106 Freiburg
bodo.grimbacher at uniklinik-freiburg.de
www.uniklinik-freiburg.de/cci

Von: <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>> on behalf of CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:cis-pidd at lists.clinimmsoc.org>>
Antworten an: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Datum: Tuesday 16 May 2017 17:11
An: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Betreff: Re: [cis-pidd] ADA2 deficiency - Infliximab dosage

That is the standard IBD load.  I suggest you do proactive therapeutic drug monitoring after the load is complete to adjust the dosing.  Check level no sooner than 4 weeks after the third dose.  Ideally a true trough is helpful so 6 weeks after third dose would be best. Infliximab is more antigenic (up to 25 percent can develop anti drug antibodies) than other anti TNFs so  I typically premedicate with Tylenol, Benadryl, and IV hydrocortisone.

Infliximab level testing is available from labcorp, ARUP, Prometheus, Mayo lab, and Miraca for those of us in the US.

Levels can be impacted by extends of disease, albumin, and degree of inflammation.

Best,

SG

Sarah C. Glover, DO, AGAF
Director, Inflammatory Bowel and Celiac Disease Program
Associate Professor of Medicine
University of Florida
PO Box 103643 <x-apple-data-detectors://1>
Gainesville, FL 32610<x-apple-data-detectors://1>
http://gastroliver.medicine.ufl.edu/ibd/
Phone (UF Health patient access center): 352-273-9400<tel:352-273-9400>
Phone (IBD research): 352-265-8971<tel:352-265-8971>
Phone (Cell): 312-933-8039<tel:312-933-8039>
Fax 352-265-8979<tel:352-265-8979>​


Sent from my iPhone

On May 16, 2017, at 11:00 AM, CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:cis-pidd at lists.clinimmsoc.org>> wrote:

Dear all,

I am planning to treat an ADA2 deficient patient with Infliximab and would like to know the dosage and the dosing intervall already used sucessfully.
Is it 5mg/kg at week 0, 2, 6 and thereafter every 8 weeks?

Thank you and best regards,

Fabian


Fabian Hauck, MD, PhD

Head Immunodeficiency Unit and Immunological Diagnostics Laboratoy
Pediatrics / Pediatric Hematology and Oncology / Immunology (DGfI)

Dr. von Hauner Children’s Hospital
Klinikum der Universität München
Lindwurmstr. 4, 80337 München
Germany

Tel.: +49 89 4400-53931
Fax: +49 89 4400-53964
E-Mail: fabian.hauck at med.uni-muenchen.de<mailto:fabian.hauck at med.uni-muenchen.de>


www.klinikum.uni-muenchen.de<http://www.klinikum.uni-muenchen.de/>

<image001.png>

Das Klinikum der Universität München ist eine Anstalt des öffentlichen Rechts (AöR)
The Klinikum der Universität München is an Institution under Public Law





---

You are currently subscribed to cis-pidd as: sarah.glover at medicine.ufl.edu<mailto:sarah.glover at medicine.ufl.edu>.

To unsubscribe click here: http://cts.dundee.net/u?id=109023005.a6f267185a4a4f2c4ee42aedf0868c4d&n=T&l=cis-pidd&o=4376767

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-4376767-109023005.a6f267185a4a4f2c4ee42aedf0868c4d at lyris.dundee.net<mailto:leave-4376767-109023005.a6f267185a4a4f2c4ee42aedf0868c4d at lyris.dundee.net>

---

You are currently subscribed to cis-pidd as: bodo.grimbacher at uniklinik-freiburg.de<mailto:bodo.grimbacher at uniklinik-freiburg.de>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396431.4f2a33ac30bfa58d3a76b5fb5b03d33a&n=T&l=cis-pidd&o=4376800

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-4376800-96396431.4f2a33ac30bfa58d3a76b5fb5b03d33a at lyris.dundee.net<mailto:leave-4376800-96396431.4f2a33ac30bfa58d3a76b5fb5b03d33a at lyris.dundee.net>

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=4378375
or send a blank email to leave-4378375-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20170517/07f3aec4/attachment-0001.html>